Sign Out
Do not administer by intravascular injection. Make sure that the needle does not penetrate a blood vessel.
To prevent hypersensitivity reactions, avoid the injection during the first five years after vaccination, both in people who have completed a primary vaccination series or in those who have received a booster dose.
Immunosuppressive therapy or immunodeficiency may induce a reduced antibody response to active immunisation. In such cases, it is recommended that the vaccination should be delayed until the end of treatment or check if the subject has reached protective levels. However vaccination of subjects with chronic immunosuppression, such as HIV infection is recommended if the underlying condition allows induction of an antibody response, and even if it is limited.
If Guillain-Barré syndrome or brachial neuritis occurred after having received a previous vaccine containing tetanus toxoid, the decision to administer any vaccine containing tetanus toxoid must be based on careful consideration of the benefits and potential risks, whether the primary immunization schedule has been completed or not. Vaccination is generally justified when the primary immunization schedule is incomplete (for example, those who have received less than three doses).
As with all injectable vaccines, a 1:1,000 adrenaline solution should always be prepared for immediate use, in case an anaphylactic reaction occurs.
Effects on ability to drive and use machines: No studies have been conducted on the effects on the ability to drive and use machines.
